{"entity":"stryker","id":"ent_stryker","name":"Stryker Corporation","from":"2025-11-10","to":"2026-11-10","page":"https://asof.is/record/stryker/diff?from=2025-11-10&to=2026-11-10","summary":"Between 2025-11-10 and 2026-11-10, Stryker Corporation's record changed in 20 facts: 4 replaced (net income $2.99 billion → $3.25 billion; operating income $3.69 billion → $4.89 billion; research and development $1.47 billion → $1.62 billion and 1 more), 8 added, 8 ended; 12 unchanged.","counts":{"changed":20,"added":8,"ended":8,"replaced":4,"unchanged":12,"skipped_posts":{"from":0,"to":0}},"by_predicate":[{"predicate":"cash_and_equivalents","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"quarterly_net_income","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"quarterly_operating_income","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"quarterly_research_and_development","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"quarterly_revenue","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"shares_outstanding","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"total_assets","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"total_equity","added":1,"ended":1,"replaced":0,"unchanged":0},{"predicate":"net_income","added":0,"ended":0,"replaced":1,"unchanged":0},{"predicate":"operating_income","added":0,"ended":0,"replaced":1,"unchanged":0},{"predicate":"research_and_development","added":0,"ended":0,"replaced":1,"unchanged":0},{"predicate":"revenue","added":0,"ended":0,"replaced":1,"unchanged":0},{"predicate":"acquired","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"agreement","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"cfo","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"cik","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"fiscal_year_end","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"headquarters","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"listed_on","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"registrant_name","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"sic_industry","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"state_of_incorporation","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"ticker","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"website","added":0,"ended":0,"replaced":0,"unchanged":1}],"added":[{"id":"clm_081F1213F18C","predicate":"cash_and_equivalents","value":"3,271,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 3,271,000,000 United States dollar\", as of 2026-09-30. Claim clm_081F1213F18C, https://asof.is/claim/clm_081F1213F18C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000061/0000310764-26-000061-index.htm.","url":"https://asof.is/claim/clm_081F1213F18C","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310764/000031076426000061/0000310764-26-000061-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2026, filed 2026-10-30"}},{"id":"clm_35B4FBD845E2","predicate":"quarterly_net_income","value":"753,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 753,000,000 United States dollar\", as of 2026-09-30. Claim clm_35B4FBD845E2, https://asof.is/claim/clm_35B4FBD845E2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000061/0000310764-26-000061-index.htm.","url":"https://asof.is/claim/clm_35B4FBD845E2","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310764/000031076426000061/0000310764-26-000061-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2026, filed 2026-10-30"}},{"id":"clm_AE0E97F1AC79","predicate":"quarterly_operating_income","value":"1,034,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 1,034,000,000 United States dollar\", as of 2026-09-30. Claim clm_AE0E97F1AC79, https://asof.is/claim/clm_AE0E97F1AC79, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000061/0000310764-26-000061-index.htm.","url":"https://asof.is/claim/clm_AE0E97F1AC79","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310764/000031076426000061/0000310764-26-000061-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2026, filed 2026-10-30"}},{"id":"clm_9A4F807637F2","predicate":"quarterly_research_and_development","value":"433,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 433,000,000 United States dollar\", as of 2026-09-30. Claim clm_9A4F807637F2, https://asof.is/claim/clm_9A4F807637F2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000061/0000310764-26-000061-index.htm.","url":"https://asof.is/claim/clm_9A4F807637F2","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310764/000031076426000061/0000310764-26-000061-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2026, filed 2026-10-30"}},{"id":"clm_08A9619123F8","predicate":"quarterly_revenue","value":"6,520,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 6,520,000,000 United States dollar\", as of 2026-09-30. Claim clm_08A9619123F8, https://asof.is/claim/clm_08A9619123F8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000061/0000310764-26-000061-index.htm.","url":"https://asof.is/claim/clm_08A9619123F8","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310764/000031076426000061/0000310764-26-000061-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2026, filed 2026-10-30"}},{"id":"clm_2175673D8B90","predicate":"shares_outstanding","value":"380,691,004 shares","valid_from":"2026-09-30","valid_to":null,"published":"2026-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 380,691,004 shares\", as of 2026-09-30. Claim clm_2175673D8B90, https://asof.is/claim/clm_2175673D8B90, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000061/0000310764-26-000061-index.htm.","url":"https://asof.is/claim/clm_2175673D8B90","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310764/000031076426000061/0000310764-26-000061-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2026, filed 2026-10-30"}},{"id":"clm_B99FA67BFA76","predicate":"total_assets","value":"47,247,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 47,247,000,000 United States dollar\", as of 2026-09-30. Claim clm_B99FA67BFA76, https://asof.is/claim/clm_B99FA67BFA76, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000061/0000310764-26-000061-index.htm.","url":"https://asof.is/claim/clm_B99FA67BFA76","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310764/000031076426000061/0000310764-26-000061-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2026, filed 2026-10-30"}},{"id":"clm_7FA8580013B6","predicate":"total_equity","value":"23,457,000,000 United States dollar","valid_from":"2026-09-30","valid_to":null,"published":"2026-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 23,457,000,000 United States dollar\", as of 2026-09-30. Claim clm_7FA8580013B6, https://asof.is/claim/clm_7FA8580013B6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000061/0000310764-26-000061-index.htm.","url":"https://asof.is/claim/clm_7FA8580013B6","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310764/000031076426000061/0000310764-26-000061-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2026","published_at":"2026-10-30T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q3 FY2026, filed 2026-10-30"}}],"ended":[{"id":"clm_3DD0AACD5492","predicate":"cash_and_equivalents","value":"3,256,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2025-12-31","published":"2025-10-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation cash and equivalents: 3,256,000,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_3DD0AACD5492, https://asof.is/claim/clm_3DD0AACD5492, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000129/0000310764-25-000129-index.htm.","url":"https://asof.is/claim/clm_3DD0AACD5492","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_01F1E3D2AFA5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310764/000031076425000129/0000310764-25-000129-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-31T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2025, filed 2025-10-31"}},{"id":"clm_D8A0D107B7F6","predicate":"quarterly_net_income","value":"859,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2026-03-31","published":"2025-10-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly net income: 859,000,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_D8A0D107B7F6, https://asof.is/claim/clm_D8A0D107B7F6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000129/0000310764-25-000129-index.htm.","url":"https://asof.is/claim/clm_D8A0D107B7F6","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E3E05BB77AD2","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310764/000031076425000129/0000310764-25-000129-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-31T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2025, filed 2025-10-31"}},{"id":"clm_B72036341823","predicate":"quarterly_operating_income","value":"1,135,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2026-03-31","published":"2025-10-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly operating income: 1,135,000,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_B72036341823, https://asof.is/claim/clm_B72036341823, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000129/0000310764-25-000129-index.htm.","url":"https://asof.is/claim/clm_B72036341823","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F2E70133269B","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310764/000031076425000129/0000310764-25-000129-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-31T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2025, filed 2025-10-31"}},{"id":"clm_840CBFF64E83","predicate":"quarterly_research_and_development","value":"410,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2026-03-31","published":"2025-10-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly research and development: 410,000,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_840CBFF64E83, https://asof.is/claim/clm_840CBFF64E83, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000129/0000310764-25-000129-index.htm.","url":"https://asof.is/claim/clm_840CBFF64E83","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0B263C3D2C56","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310764/000031076425000129/0000310764-25-000129-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-31T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2025, filed 2025-10-31"}},{"id":"clm_8E877412AAEE","predicate":"quarterly_revenue","value":"6,057,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2026-03-31","published":"2025-10-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation quarterly revenue: 6,057,000,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_8E877412AAEE, https://asof.is/claim/clm_8E877412AAEE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000129/0000310764-25-000129-index.htm.","url":"https://asof.is/claim/clm_8E877412AAEE","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_14534DCC89AD","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310764/000031076425000129/0000310764-25-000129-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-31T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2025, filed 2025-10-31"}},{"id":"clm_53217597F2B0","predicate":"shares_outstanding","value":"382,423,648 shares","valid_from":"2025-09-30","valid_to":"2026-01-31","published":"2025-10-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation shares outstanding: 382,423,648 shares\", as of 2025-09-30 (until 2026-01-31). Claim clm_53217597F2B0, https://asof.is/claim/clm_53217597F2B0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000129/0000310764-25-000129-index.htm.","url":"https://asof.is/claim/clm_53217597F2B0","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_E8EFDF649C1E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310764/000031076425000129/0000310764-25-000129-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-31T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2025, filed 2025-10-31"}},{"id":"clm_1B2097560390","predicate":"total_assets","value":"47,057,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2025-12-31","published":"2025-10-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total assets: 47,057,000,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_1B2097560390, https://asof.is/claim/clm_1B2097560390, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000129/0000310764-25-000129-index.htm.","url":"https://asof.is/claim/clm_1B2097560390","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1C3EDF939FE8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310764/000031076425000129/0000310764-25-000129-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-31T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2025, filed 2025-10-31"}},{"id":"clm_5C2DB82E169E","predicate":"total_equity","value":"21,785,000,000 United States dollar","valid_from":"2025-09-30","valid_to":"2025-12-31","published":"2025-10-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation total equity: 21,785,000,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_5C2DB82E169E, https://asof.is/claim/clm_5C2DB82E169E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000129/0000310764-25-000129-index.htm.","url":"https://asof.is/claim/clm_5C2DB82E169E","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_6E60905B1047","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310764/000031076425000129/0000310764-25-000129-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-31T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q3 FY2025, filed 2025-10-31"}}],"replaced":[{"predicate":"net_income","from":{"id":"clm_8D6AA07518A6","predicate":"net_income","value":"2,993,000,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation net income: 2,993,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_8D6AA07518A6, https://asof.is/claim/clm_8D6AA07518A6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000023/0000310764-25-000023-index.htm.","url":"https://asof.is/claim/clm_8D6AA07518A6","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_67A3BD4DA5CA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310764/000031076425000023/0000310764-25-000023-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-12T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2024, filed 2025-02-12"}},"to":{"id":"clm_67A3BD4DA5CA","predicate":"net_income","value":"3,246,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation net income: 3,246,000,000 United States dollar\", as of 2025-12-31. Claim clm_67A3BD4DA5CA, https://asof.is/claim/clm_67A3BD4DA5CA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000010/0000310764-26-000010-index.htm.","url":"https://asof.is/claim/clm_67A3BD4DA5CA","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310764/000031076426000010/0000310764-26-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-11T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2025, filed 2026-02-11"}}},{"predicate":"operating_income","from":{"id":"clm_5442DF8B2745","predicate":"operating_income","value":"3,689,000,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation operating income: 3,689,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_5442DF8B2745, https://asof.is/claim/clm_5442DF8B2745, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000023/0000310764-25-000023-index.htm.","url":"https://asof.is/claim/clm_5442DF8B2745","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_57564F6F4242","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310764/000031076425000023/0000310764-25-000023-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-12T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2024, filed 2025-02-12"}},"to":{"id":"clm_57564F6F4242","predicate":"operating_income","value":"4,889,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation operating income: 4,889,000,000 United States dollar\", as of 2025-12-31. Claim clm_57564F6F4242, https://asof.is/claim/clm_57564F6F4242, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000010/0000310764-26-000010-index.htm.","url":"https://asof.is/claim/clm_57564F6F4242","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310764/000031076426000010/0000310764-26-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-11T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2025, filed 2026-02-11"}}},{"predicate":"research_and_development","from":{"id":"clm_EC0F2D5205F4","predicate":"research_and_development","value":"1,466,000,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation research and development: 1,466,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_EC0F2D5205F4, https://asof.is/claim/clm_EC0F2D5205F4, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000023/0000310764-25-000023-index.htm.","url":"https://asof.is/claim/clm_EC0F2D5205F4","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_DAC9135A26A9","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310764/000031076425000023/0000310764-25-000023-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-12T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2024, filed 2025-02-12"}},"to":{"id":"clm_DAC9135A26A9","predicate":"research_and_development","value":"1,623,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation research and development: 1,623,000,000 United States dollar\", as of 2025-12-31. Claim clm_DAC9135A26A9, https://asof.is/claim/clm_DAC9135A26A9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000010/0000310764-26-000010-index.htm.","url":"https://asof.is/claim/clm_DAC9135A26A9","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310764/000031076426000010/0000310764-26-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-11T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2025, filed 2026-02-11"}}},{"predicate":"revenue","from":{"id":"clm_D8DB92A640FC","predicate":"revenue","value":"22,595,000,000 United States dollar","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation revenue: 22,595,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_D8DB92A640FC, https://asof.is/claim/clm_D8DB92A640FC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076425000023/0000310764-25-000023-index.htm.","url":"https://asof.is/claim/clm_D8DB92A640FC","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_2711436885CB","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310764/000031076425000023/0000310764-25-000023-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-12T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2024, filed 2025-02-12"}},"to":{"id":"clm_2711436885CB","predicate":"revenue","value":"25,116,000,000 United States dollar","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Stryker Corporation revenue: 25,116,000,000 United States dollar\", as of 2025-12-31. Claim clm_2711436885CB, https://asof.is/claim/clm_2711436885CB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/310764/000031076426000010/0000310764-26-000010-index.htm.","url":"https://asof.is/claim/clm_2711436885CB","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/310764/000031076426000010/0000310764-26-000010-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2025","published_at":"2026-02-11T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2025, filed 2026-02-11"}}}],"rule":"Two states compared by claim id: in both, unchanged; only on to, added; only on from, ended. An ended and an added claim on one predicate are a replacement when the ended one points to the added (superseded_by), or the predicate has exactly one of each and the added begins the day the ended ends. Added rows are labelled for to, ended rows for from. Posts and Hugging Face repos are counted in skipped_posts, not listed.","legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}